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Abstract
The two primary causal dimensions of age-related disease are rate and function.
Change in rate of disease development shifts the age of onset. Change in physi-
ological function provides necessary steps in disease progression. A causal factor
may alter the rate of physiological change, but that causal factor itself may have no
direct physiological role. Alternatively, a causal factor may provide a necessary phys-
iological function, but that causal factor itself may not alter the rate of disease onset.
The rate-function duality provides the basis for solving puzzles of age-related disease.
Causal factors of cancer illustrate the duality between rate processes of discovery,
such as somatic mutation, and necessary physiological functions, such as invasive
penetration across tissue barriers. Examples from cancer suggest general principles
of age-related disease.
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Introduction
If you inherit certain mutations of the p53 gene, you have
an increased risk of cancer1. If you do not inherit such mu-
tations, but nonetheless develop cancer, your tumor likely
has a somatically acquired mutation in the apoptotic path-
ways associated with p532.
In each case, p53-associated mutation has a causal effect on
cancer.
The inherited mutation increases the rate of cancer devel-
opment and shifts disease onset to earlier ages. Shift in age
of onset defines a cause of cancer.
The physiological change, breakdown of apoptosis, pro-
vides a necessary function in cancer development. Physi-
ological necessity defines a cause of cancer.
Duality of rate and function
A factor that shifts the age of onset may not be important
physiologically.
For example, a rise in somatic mutation may increase the
rate of breakdown in apoptosis. Rapid breakdown in apop-
tosis shifts the age of onset. In this case, increased mutation
directly changes the rate of onset but does not itself directly
change physiological function.
A factor that changes physiology may not shift the age of
onset.
For example, tumors often adapt their metabolism to hy-
poxic conditions3,4. The necessary physiological changes
may arise relatively rapidly in response to hypoxia. The
functional changes are a necessary cause of tumor develop-
ment. However, rapidly acquired changes do not causally
influence the rate of cancer development or the age of on-
set.
The duality of rate and function recur. Each causal factor
must be evaluated simultaneously in two dimensions. How
does a causal factor alter the rate of tumor development?
How does a causal factor alter the physiological function of
the tumor?
Identifying causal factors
What sort of evidence could we collect to show that a factor
plays a causal role in cancer?
Shift in age of onset is often studied in experiments5. Start
with a particular mouse genotype. Create a knockout vari-
ant that lacks expression of a particular gene. Compare the
age of tumor onset between the initial and knockout types.
If the incidence curve in the knockout shifts to earlier ages,
then loss of the target gene is a potential cause of cancer.
In general, we can relate the change in a potential causal
factor to the change in the rate of cancer development and
age of onset.
Alternatively, studies may focus on physiological function.
Experimentally, one may reverse a physiological change
and measure the abrogation of a cancerous state. Success
points to a physiologically necessary function.
In general, we can relate the change in a potential causal
factor to the change in the physiological function of a tu-
mor.
Large datasets allow one to correlate changes with cancer.
A strong correlation suggests a candidate cause. However,
the correlation may identify a factor that either increases
the rate of cancer development or has a necessary physio-
logical function in tumors.
Solving different puzzles
Full analysis requires simultaneous study of rate and func-
tion. The relative roles of the two causal dimensions vary
with particular puzzles.
Treatment requires a dual focus on interfering with cancer’s
physiological function and on altering the rate of escape
from treatment. One typically begins by finding a way to
block an essential physiological function. An initially suc-
cessful block loses value in proportion to the rate at which
the tumor escapes control.
Prevention depends only on slowing the rate of onset. Physi-
ologically important functions may provide targets for slow-
ing onset. However, some processes may significantly slow
the rate of onset yet be physiologically unimportant. For ex-
ample, the rate of onset may be increased by wound heal-
ing associated with a temporary increase the rate of cell
division, by increased epigenetic instability, or by increased
mutagenesis. Reduction of these rate-enhancing processes
aids prevention.
Early detection may focus on direct evidence of functional
change. Small precancerous tumors associate with cancer-
ous changes in physiology. Elevated levels of specific mark-
ers associate with cancerous physiological changes. Alter-
natively, one may focus on indicators associated with rate
processes that shift the age of onset. Such indicators sug-
gest elevated risk and the need to screen more carefully for
direct signs of physiological change.
Basic understanding of onset ultimately depends only on
rate. Each causal factor must be evaluated within the com-
plex interacting ensemble of processes that determine the
overall rate of onset5. One must study how change in a
causal factor shifts the age of onset within a particular back-
ground of other rate processes. Although only rate matters,
function provides clues about which factors may influence
rate.
Basic understanding of physiology depends only on function.
An important function does not necessarily influence rate.
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Rate is the search, function is the find
In general, the relation between rate and function is sim-
ilar to the relation between the process of discovery and
the actual discovery itself6. In tumor evolution, the dual-
ity becomes the relation between the processes that change
physiological function and the physiological function itself.
For example, somatic mutation and natural selection be-
tween cellular lineages are processes that change physio-
logical function. Acquired ability to invade across tissue
barriers is a common physiological function of tumors.
Age-related disease
Age-related disease expresses the same duality of rate and
function. Factors that influence rate alter the timing of dis-
ease onset. Factors that influence physiological function
may be important targets for treatment, prevention and
early detection.
Basic understanding always demands a clear separation of
rate and function. Only from that two-dimensional per-
spective can one solve particular puzzles. The solutions
inevitably express the interactions of rate and function.
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